Karin Richter

ORCID: 0000-0002-0526-9215
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cervical Cancer and HPV Research
  • Hepatitis B Virus Studies
  • Genital Health and Disease
  • Vaccine Coverage and Hesitancy
  • HIV/AIDS Research and Interventions
  • Global Cancer Incidence and Screening
  • Molecular Biology Techniques and Applications
  • Cleft Lip and Palate Research
  • Infection Control in Healthcare
  • Vector-Borne Animal Diseases
  • Reproductive tract infections research
  • HIV/AIDS drug development and treatment
  • Epigenetics and DNA Methylation
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Urinary and Genital Oncology Studies
  • Multiple and Secondary Primary Cancers
  • Bioenergy crop production and management
  • Hepatitis Viruses Studies and Epidemiology
  • Herpesvirus Infections and Treatments
  • Viral-associated cancers and disorders
  • Prion Diseases and Protein Misfolding
  • T-cell and Retrovirus Studies
  • Innovation and Socioeconomic Development
  • Virology and Viral Diseases
  • HIV/AIDS Impact and Responses

University of Pretoria
2014-2025

Lancet Laboratories
2018-2025

Stellenbosch University
2023-2024

National Health Laboratory Service
2006-2021

University of Erfurt
2013

Women accessing the public health system in Gauteng province, South Africa are largely unscreened for cervical cancer and have a high background prevalence of human immunodeficiency virus (HIV) infection.This cross-sectional study describes age-specific papillomavirus (HPV) infection cytological abnormalities among this urban peri-urban population.Over period March 2009 - September 2011, 1 524 women attending sector primary healthcare clinics were invited to participate screening study. All...

10.7196/samj.6514 article EN cc-by-nc South African Medical Journal 2013-03-01

Objective To assess the performance of APTIMA ® HPV E6/E7 mRNA assay (AHPV) with 16 and 18/45 genotyping (AHPV-GT) cytology in detecting cervical cancer precancer HIV positive negative women South Africa. Methods A multicentre cross-sectional study was performed aged 25–64 (n = 992) AHPV AHPV-GT reflex testing. All screen-positive a random subset screen-negative were referred for colposcopy biopsy. Results On cytology, low-grade squamous intraepithelial lesion (LSIL) or higher found 9.7%...

10.1177/09691413251317926 article EN Journal of Medical Screening 2025-02-21

Abstract Background Cervical cancer screening strategies should ideally be informed by population-specific data. Strategies recommended for secondary prevention, are often inadequately studied in populations with high cervical disease burdens. This report describes the test performance measured against CIN2 + /CIN3 histology HIV-positive women (HPW) and HIV-negative (HNW) aim to determine most effective identify South African at risk. Methods Primary using visual inspection, cytology HPV DNA...

10.1186/s13027-024-00586-3 article EN cc-by Infectious Agents and Cancer 2024-05-09

Background: To evaluate the prevalence of human papilloma virus (HPV) infection and types in oral cervix mucosa treatment‐naïve HIV‐1‐positive women with CD4 counts less than 300 cells per ml no HPV‐associated lesions. Methods: Oral epithelium was harvested from buccal lateral borders tongue cervical samples were collected endocervical area 30 women, 22–64 years old. Cytobrush Plus cell collectors used for sampling both anatomical areas. Genital pathology, obstetric gynaecological history,...

10.1111/j.1600-0714.2008.00670.x article EN Journal of Oral Pathology and Medicine 2008-09-08

Background. Human papillomavirus (HPV) infection is well known to be associated with head and neck cancers (HNCs). HPV-associated HNCs are related sexual behaviour, particularly the lifetime number of oral sex partners, but epidemiology oropharyngeal HPV in South African men has not yet been studied. Objectives. To determine strain prevalence factors a selected male population Pretoria, Africa (SA). Methods. Male factory workers were recruited. Oral rinse gargle samples tested for 37 types...

10.7196/samj.7542 article EN South African Medical Journal 2014-03-26

To determine the performance of molecular screening strategies for detection cervical intraepithelial neoplasia grade 3 or worse (CIN3+) in comparison with cytology women living HIV.Post-hoc analysis using data from a South African study cohort.Cytology and human papillomavirus (HPV)-based were evaluated, including single test FAM19A4/miR124-2 methylation triage strategies. Participants underwent colposcopy-directed biopsy. Valid results on cytology, HPV status, 16/18 genotyping histology...

10.1097/qad.0000000000002325 article EN cc-by-nc-nd AIDS 2019-08-02

Cervical cancer is the most common among women in Sub-Saharan Africa. treatable if detected timeously, yet only 20% of South African have ever been for a Pap smear their lifetime due to limited access screening, transport or child care responsibilities.To evaluate acceptability self-collection cervical screening. We aimed identify which device prefer and they would consider using them routine screening.HIV-positive (>18 years) from urban rural HIV clinics were interviewed following an...

10.11604/pamj.2014.17.189.3454 article EN cc-by Pan African Medical Journal 2014-01-01

<h3>Objectives</h3> Cervical cancer is the most common cause of cancer-related deaths among South African women. Viral types associated with cervical may differ not only between countries and regions, but possibly also human immunodeficiency virus (HIV)–infected noninfected <h3>Methods</h3> In a population high HIV prevalence, papillomavirus (HPV)–type infections detected DNA analyses were reported in cohort 299 women diagnosed invasive cancer. <h3>Results</h3> One hundred fifty-four tested...

10.1097/igc.0000000000000422 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2015-05-07

To evaluate the performance of hypermethylation analysis ASCL1, LHX8 and ST6GALNAC5 in physician-taken cervical scrapes for detection cancer intraepithelial neoplasia (CIN) grade 3 women living with HIV (WLHIV) South Africa.Samples from a prospective observational cohort study were used these analyses. Two cohorts included: WLHIV who invited screening (n = 321) gynaecologic outpatient referred evaluation abnormal cytology or biopsy proven 108, 60% seropositive). Cervical collected all...

10.1002/jia2.25165 article EN cc-by Journal of the International AIDS Society 2018-08-01

Cervical cancer is the leading cause of cancer-related death in women South Africa. This study evaluates DNA methylation levels cervical (pre)cancer and aims to assess value high-risk human papillomavirus (hrHPV) testing analysis, alone or combination, on physician-taken scrapes detect cancer, intraepithelial neoplasia grade 3 (CIN3) an HIV-infected African population.Prospective observational multicentre cohort study.Women from a living with HIV (n = 355) referral 109, 60% seropositive)...

10.1097/qad.0000000000001583 article EN AIDS 2017-07-06

The platform provided by human papillomavirus (HPV) vaccination for linked public health interventions to improve cervical cancer prevention remains incompletely explored. Vaccine And Cervical Cancer Screen (VACCS) cross-sectional observation trials aimed evaluate the efficacy of school-based HPV with maternal screening.Girls from 29 schools in two provinces South Africa were invited writing receive vaccination. Two approaches informed consent compared, namely an audiovisual presentation...

10.1136/ijgc-2021-003079 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2022-01-25

Human papillomavirus (HPV)-based primary screening guidelines are based on test performance and prevalence data generated in high-resource areas with low HIV infection rates. There is an urgent need for local disease prevalence, as well performance, among both HIV-positive HIV-negative South African (SA) women, order to inform updated guidelines. Objectives. This study describes the baseline characteristics of participants cross-sectional phase multicentric DIAgnosis Vaccine And Cervical...

10.7196/samj.2022.v112i7.16478 article EN cc-by-nc South African Medical Journal 2022-07-01

Cervical cancer is preventable and caused by persistent infection with oncogenic human papilloma virus (HPV) types. HPV screening more sensitive the preferred test. data are mainly from developed settings, purpose of this study was to investigate performance in previously unscreened HIV positive negative women.In cross sectional multicenter study, liquid based cytology testing were performed on women attending different clinics. Patients tests had colposcopy biopsy or large loop excision...

10.1136/ijgc-2022-003897 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2023-01-18

Background. In Africa, data on the relationship between oncogenic human papillomavirus (HPV) types, immune status and cervical preinvasive lesions are lacking. Methods. We investigated low-risk (lrHPV) high-risk (hrHPV) HPV types in a cohort of women with intraepithelial neoplasia (CIN) II/III confirmed histological examination, an urban setting high prevalence HIV infection. Results. Of 270 CIN II/III, 45 were HIV-negative 225 HIV-positive. HIV-infected had significantly more type...

10.7196/samj.2016.v106i6.10335 article EN cc-by-nc South African Medical Journal 2016-05-11

Occupational injuries in medical students are concerning, especially countries with a high prevalence of bloodborne infections. With more HIV-infected patients on antiretroviral treatment, appropriate post-exposure prophylaxis (PEP) depends knowledge source patients' infection status and treatment response. This study determined the number type exposure incidents, reporting practices, PEP use among at University Pretoria, South Africa.Data were collected from an anonymous voluntary...

10.3855/jidc.8940 article EN cc-by The Journal of Infection in Developing Countries 2017-01-30

Abstract Background Compared with women who are human immunodeficiency virus (HIV) negative, (WWH) have a higher papillomavirus (HPV) prevalence and increased cervical cancer risk, emphasizing the need for effective screening in this population. The present study aimed to validate methylation markers ASCL1 LHX8 primary South African cohort of WWH. Methods In post hoc analysis within DIAgnosis Vaccine And Cervical Cancer Screen (DiaVACCS) study, observational multicenter scrape samples from...

10.1093/cid/ciac801 article EN cc-by-nc-nd Clinical Infectious Diseases 2022-11-11

Background: Cervical cancer prevention in regions with limited access to screening and HPV vaccination necessitates innovative approaches. This study explored the potential of a test-and-treat strategy using mRNA tests impact cervical high-prevalence HIV population. Methods: A was conducted at three South African hospitals involving 710 under-screened, non-pregnant women (25 65 years) without known diseases. Cytology, testing, colposcopy, biopsies were performed concurrently....

10.20944/preprints202310.1811.v1 preprint EN 2023-10-27

Multipurpose vaccines (MPVs) could be formulated to prevent multiple sexually transmitted infections simultaneously. Little is known about acceptability of MPVs among vaccine health care providers (HCPs) or mothers adolescent girls. 151 and 118 girls aged 9–14 were recruited from five geographically-diverse countries: Argentina, Malaysia, South Africa, Korea, Spain. We assessed providers' preferences for single-purpose human papillomavirus (HPV) versus (including HPV+herpes simplex virus...

10.1016/j.pvr.2017.04.001 article EN cc-by-nc-nd Papillomavirus Research 2017-04-06

The identification of human papillomavirus (HPV) as the aetiological agent for cervical cancer has important implications future screening and prevention strategies. Despite availability HPV vaccines, regular adequate will remain mainstay some time to come. Molecular tests high-risk DNA E6/E7 mRNA have potential improve in developed developing countries. latest international South African private sector guidelines propose incorporation molecular testing patient management, backed by good...

10.1080/20742835.2011.11441169 article EN cc-by-nc Southern African Journal of Gynaecological Oncology 2011-01-01
Coming Soon ...